Pfizer
‘Augmented reflection’ brings GAD to life
December 13, 2012Medical Communications GAD, Pfizer, You Tube
Pfizer has worked with patient group Anxiety UK to create a new ‘enhanced reflection’ video to raise awareness of Generalised …
Eliquis in UK for AF
December 13, 2012Sales and Marketing AF, BMS, Eliquis, NVAF, Pfizer
Eliquis has been made available in the UK today to prevent stroke and systemic embolism in patients with nonvalvular atrial …
Glass particles force recall of Ranbaxy Lipitor
November 27, 2012Manufacturing and Production, Sales and Marketing Daiichi Sankyo, Lipitor, Pfizer, Ranbaxy, recall
Ranbaxy Pharmaceuticals is recalling around 40 batches of its generic atorvastatin tablets after discovering that some of the product may …
Further indications for Eliquis
November 22, 2012Sales and Marketing BMS, Eliquis, NVAF, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer’s oral blood-thinner Eliquis has been approved in Europe to prevent stroke in patients with nonvalvular atrial …
Pfizer in cystic fibrosis alliance
November 21, 2012Research and Development, Sales and Marketing CFFT, CFTR, FDA, Pfizer
Pfizer and Cystic Fibrosis Foundation Therapeutics (CFFT) have signed a six-year pre-clinical deal to find new drugs to treat the …
Pfizer and GSK end agreements
November 12, 2012Research and Development, Sales and Marketing Auxilium, GSK, Pfizer, Xenoport
Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …
Pfizer backs new biotech firm
November 6, 2012Research and Development, Sales and Marketing Pfizer, Sandwich, Ziarco
Pfizer is one of the main backers of new biotech company Ziarco, launched by four of the manufacturer’s ex-employees. The …
Pfizer stumbles in third quarter
November 2, 2012Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3
Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …
Pfizer buys NextWave Pharmaceuticals
October 23, 2012Sales and Marketing ADHD, Pfizer, Qullivant, nextwave
Pfizer is to acquire NextWave Pharmaceuticals by the end of the year in a deal that could be worth $680 …
Digital Pharma: what should we talk about?
October 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Pfizer, digital pharma, social media, twiiter
The received wisdom today among the ‘digirati’ is that the pharmaceutical industry must join in the online conversation, and to …
Survival boost for Votrient in mRCC
October 2, 2012Research and Development, Sales and Marketing GSK, Nexavar, Pfizer, Sutent, Votrient
GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …
John LaMattina: Why was bapineuzamab moved into Phase III trials?
September 24, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, John LaMattina, Pfizer, bapineuzamab
The recent news that the Pfizer/J&J Alzheimer’s Disease drug, bapineuzumab (bapi), had failed in critical clinical trials resulted in great …
Eliquis receives nod in AF
September 24, 2012Sales and Marketing BMS, CHMP, Eliquis, Pfizer, Pradaxa, Xarelto
Bristol-Myers Squibb and Pfizer have received a boost with the CHMP’s recommendation that their co-marketed oral anticoagulant Eliquis should gain …
Pharma creates non-profit R&D organisation
September 21, 2012Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma
Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
Pfizer issues guide for medicines disposal
September 18, 2012Manufacturing and Production EPA, PRDA, Pfizer
Pfizer has published a guide for the safe disposal of medicines targeted at healthcare professionals and facilities in the US. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
